These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29601306)

  • 1. Evidence-based guidelines in lower urinary tract symptoms secondary to benign prostatic hyperplasia and variation in care.
    Strope SA
    Curr Opin Urol; 2018 May; 28(3):262-266. PubMed ID: 29601306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy: revisited.
    Juliao AA; Plata M; Kazzazi A; Bostanci Y; Djavan B
    Curr Opin Urol; 2012 Jan; 22(1):34-9. PubMed ID: 22123290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
    Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
    Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management.
    Lerner LB; McVary KT; Barry MJ; Bixler BR; Dahm P; Das AK; Gandhi MC; Kaplan SA; Kohler TS; Martin L; Parsons JK; Roehrborn CG; Stoffel JT; Welliver C; Wilt TJ
    J Urol; 2021 Oct; 206(4):806-817. PubMed ID: 34384237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019.
    Foster HE; Dahm P; Kohler TS; Lerner LB; Parsons JK; Wilt TJ; McVary KT
    J Urol; 2019 Sep; 202(3):592-598. PubMed ID: 31059668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Welliver C; Feinstein L; Ward JB; Kirkali Z; Martinez-Miller EE; Matlaga BR; McVary K
    Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):269-273. PubMed ID: 34545201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of patients with benign prostate enlargement and storage symptoms in everyday clinical practice.
    Zdrojowy R; Owczarek AJ; Olszanecka-Glinianowicz M; Almgren-Rachtan A; Chudek J
    Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5248-5254. PubMed ID: 34486700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A practical primary care approach to lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH-LUTS).
    Rosenberg MT; Witt ES; Miner M; Barkin J
    Can J Urol; 2014 Jun; 21 Suppl 2():12-24. PubMed ID: 24978629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced clinical decisions for management of benign prostatic hyperplasia using patient-reported outcomes: protocol for a prospective observational study.
    Glaser AP; Smith AR; Maglaque D; Helfand BT; Mohamed R; An H; Marquez M; Talaty P; Carolan P; Geller AM; Farina FR; Jensen SE; Griffith JW
    BMC Urol; 2024 May; 24(1):110. PubMed ID: 38773430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The New American Urological Association Benign Prostatic Hyperplasia Clinical Guidelines: 2019 Update.
    Dornbier R; Pahouja G; Branch J; McVary KT
    Curr Urol Rep; 2020 Jul; 21(9):32. PubMed ID: 32607874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Singapore Urological Association Clinical Guidelines for Male Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia.
    Singapore Urological Association Male Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Guidelines Committee 2015
    Singapore Med J; 2017 Aug; 58(8):473-480. PubMed ID: 28848988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How to evaluate BPH-related SBAUs in clinical practice and research?].
    Descazeaud A; Robert G; de La Taille A
    Prog Urol; 2018 Nov; 28(15):830-838. PubMed ID: 30220536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign prostatic hyperplasia and lower urinary tract symptoms. A review of current evidence.
    Carrero-López VM; Cózar-Olmo JM; Miñana-López B
    Actas Urol Esp; 2016 Jun; 40(5):288-94. PubMed ID: 26823069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of lower urinary tract symptoms associated with benign prostatic hyperplasia in elderly patients with a new diagnostic, therapeutic and care pathway.
    Carbone A; Fuschi A; Al Rawashdah SF; Al Salhi Y; Velotti G; Ripoli A; Autieri D; Palleschi G; Pastore AL
    Int J Clin Pract; 2016 Sep; 70(9):734-43. PubMed ID: 27561366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population.
    Strope SA; Elliott SP; Saigal CS; Smith A; Wilt TJ; Wei JT;
    Urology; 2011 Jul; 78(1):3-9. PubMed ID: 21601254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign prostatic hyperplasia and urinary symptoms: Evaluation and treatment.
    Mobley D; Feibus A; Baum N
    Postgrad Med; 2015 Apr; 127(3):301-7. PubMed ID: 25823641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Options for the treatment of benign prostatic hyperplasia.
    Plante M; Wachterman J; Perrapato S
    Crit Rev Eukaryot Gene Expr; 2012; 22(4):281-7. PubMed ID: 23272798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of benign prostatic hyperplasia in geriatric patients-use and limitations of existing guidelines].
    Schoeb DS; Wullich B; Dürschmied D; Heimbach B; Heupel-Reuter M; Gross AJ; Wilhelm K; Gratzke C; Miernik A
    Urologe A; 2019 Sep; 58(9):1029-1038. PubMed ID: 31451881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.